Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma
Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Nivolumab is an active treatment in patients with metastatic melanoma. We report a case of a patient with metastatic malignant melanoma who was given nivolumab as an advanced-line treatment. She received nivolumab 3 mg/kg every 2 weeks for 4 cycles and developed aplastic anemia. To the best of our knowledge, there are only three published case repo...
Alternative Titles
Full title
Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1750c3b41b734430a34e2b3bd42e3ab8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1750c3b41b734430a34e2b3bd42e3ab8
Other Identifiers
ISSN
1662-6575
E-ISSN
1662-6575
DOI
10.1159/000495980
